Abstract: The present application provides substituted N-(pyridin-2-yl)acetamide derivatives of formula (I), which are therapeutically useful as CDK12/13 inhibitors. These compounds are useful in the treatment and/or prevention of diseases and/or disorders associated with CDK12/13 in a mammal. In addition, the present application provides preparation of the compounds and pharmaceutical compositions comprising at least one of the substituted N-(pyridin-2-yl)acetamide derivatives of formula (I) or a pharmaceutically acceptable salt, an N-oxide or a stereoisomer thereof.
| # | Name | Date |
|---|---|---|
| 1 | 202547006887-STATEMENT OF UNDERTAKING (FORM 3) [28-01-2025(online)].pdf | 2025-01-28 |
| 2 | 202547006887-FORM 1 [28-01-2025(online)].pdf | 2025-01-28 |
| 3 | 202547006887-DECLARATION OF INVENTORSHIP (FORM 5) [28-01-2025(online)].pdf | 2025-01-28 |
| 4 | 202547006887-COMPLETE SPECIFICATION [28-01-2025(online)].pdf | 2025-01-28 |
| 5 | 202547006887-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [28-01-2025(online)].pdf | 2025-01-28 |
| 6 | 202547006887-FORM 18 [30-01-2025(online)].pdf | 2025-01-30 |
| 7 | 202547006887-Proof of Right [02-07-2025(online)].pdf | 2025-07-02 |